Cloud DX Announces Proposed $2.8 Million Private Placement
KITCHENER, ON / ACCESSWIRE / April 8, 2024 / Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX)(OTC:CDXFF) is pleased...
Month: April 2024
Jackpot Digital to Exhibit Electronic Dealerless Poker Tables at the 2024 Indian Gaming Tradeshow in Anaheim
VANCOUVER, BC / ACCESSWIRE / April 8, 2024 / Jackpot Digital Inc. (the "Company" or "Jackpot") (TSXV:JJ)(TSXV:JJ.WT.B)(TSXV:JJ.WT.C)(OTCQB:JPOTF) (Frankfurt:LVH3), a leading...
Condor and Element79 Reschedule March 2024 Lucero Payment
VANCOUVER, BC / ACCESSWIRE / April 8, 2024 / Condor Resources Inc. - ("Condor" or the "Company") (TSXV:CN) announces that...
Temas Resources Completes First Tranche of Private Placement
VANCOUVER, BC / ACCESSWIRE / April 8, 2024 / Temas Resources Corp. (CSE:TMAS)(OTCQB:TMASF) ("Temas" or the "Company") is pleased to...
Synaptics Astra™ AI-Native IoT Platform Launches with SL-Series Embedded Processors and Machina Foundation Series Development Kit
SAN JOSE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today launched the Synaptics Astra platform with...
Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment
STOCKHOLM, April 8, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that the Company...
Avant Brands Launches $3.88 Million Non-Brokered Private Placement Offering
KELOWNA, BC / ACCESSWIRE / April 8, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
Pampa Metals Upsizes Fully Subscribed Private Placement to $2m
VANCOUVER, BC / ACCESSWIRE / April 8, 2024 / Pampa Metals Corp. ("Pampa Metals" or the "Company") (CSE:PM)(FSE:FIRA)(OTCQB:PMMCF) has upsized...
WTW announces appointment of Sean Plankey as Global Leader Cybersecurity Software
LONDON, April 08, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced...
OneSoft Solutions Announces Expansion of Operations to EMEA
Sales Efforts To Target 250,000+ Pipeline Miles EDMONTON, AB / ACCESSWIRE / April 8, 2024 / OneSoft Solutions Inc. (the...
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
VANCOUVER, BC / ACCESSWIRE / April 8, 2024 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused...
Wesdome Provides Kiena Exploration Update; Drilling Continues to Grow Kiena Deep and Intercept High Grades Near Mine Infrastructure
TORONTO, April 08, 2024 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) today...
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
SHL’s SmartHeart portable 12-lead ECG technology successfully participated in the U.S. Army’s Project Convergence – Capstone 4 experiment (PC-C4), demonstrating...
SIRONA BIOCHEM Corporate Update April 2024
VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or...
Aker BP trading update for Q1-2024
LYSAKER, Norway, April 8, 2024 /PRNewswire/ -- Aker BP (OSE: AKRBP) (OTCQX: AKRBF) (OTCQX: AKRBY) today announces its preliminary production...
Aker BP trading update for Q1-2024
LYSAKER, Norway, April 8, 2024 /PRNewswire/ -- Aker BP (OSE: AKRBP) (OTCQX: AKRBF) (OTCQX: AKRBY) today announces its preliminary production...
Drei-Jahres-Follow-up-Daten aus Phase-1-Studie mit individualisiertem mRNA-Immuntherapie-Kandidaten zeigen eine anhaltende Immunantwort und ein verringertes Rückfallrisiko bei einigen Patienten mit reseziertem Bauchspeicheldrüsenkrebs
MAINZ, Deutschland, 7. April, 2024 - BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) gab heute Drei-Jahres-Follow-up-Daten aus einer Phase-1-Studie...
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLCEmerging data show non-classical EGFR mutations...
BridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibute-CM Phase 3 Study in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
- In this exploratory substudy, treatment with acoramidis was associated with possible cardiac structural and functional improvement compared with placebo,...
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
– Study Met Primary Endpoint Demonstrating Clinically Significant Additive Reductions in Ambulatory Systolic Blood Pressure of Up to 12.1 mmHg...
GLP Works with Foundry for AI by Rackspace (FAIR) Experts to Integrate Microsoft Azure OpenAI Service to Drive Innovative Asset Management Strategies
SINGAPORE, April 07, 2024 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), the leading end-to-end, hybrid multicloud solutions company, today announced...
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
SAN DIEGO, April 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the...
Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma
TARRYTOWN, N.Y., April 07, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the oral plenary session presentation...
MoonFox Analysis | Xiaomi Cars were Finally Released, and How About the Group’s Confidence?
About us: Aurora Mobile (NASDAQ: JG) established in 2011, is a leading customer engagement and marketing technology service provider in...
iTeos präsentiert präklinische Daten zu EOS-984 auf der Jahrestagung 2024 der American Association for Cancer Research und zeigt die Wiederherstellung der T-Zell-Aktivität durch Unterdrückung von Adenosin
WATERTOWN, Massachusetts, und GOSSELIES, Belgien, April 07, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), ein biopharmazeutisches Unternehmen im...
Evaxion und nicht offengelegter Kooperationspartner veröffentlichen vielversprechende Ergebnisse für EVX-B1-Impfstoff-Antigene gegen Staphylococcus aureus-Infektionen
KOPENHAGEN, Dänemark, April 08, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) („Evaxion“ oder das „Unternehmen“), ein Biotechnologie-Unternehmen in...
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
– Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event (MACE-4) Compared...
EHang Secures Production Certificate from CAAC, Clearing Path for Mass Production of EH216-S Pilotless eVTOL Aircraft
GUANGZHOU, China, April 07, 2024 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading...
Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE CTC HER2 assay being developed for HER2 targeted drugs and antibody...
Angle PLC Announces Parsortix HER2 Assay Showcased at AACR 2024
PARSORTIX HER2 ASSAY SHOWCASED AT PRESTIGIOUS INTERNATIONAL CANCER CONFERENCE CTC HER2 assay being developed for HER2 targeted drugs and antibody...
Bradda Head Lithium Ltd Announces Channel Sampling at San Domingo and Basin Update
Bradda Head Reports High-Grade Channel Sampling at San Domingo and Basin Project Update BRITISH VIRGIN ISLANDS / ACCESSWIRE / April...
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
-- Findings Presented on VASCEPA/VAZKEPA Utility in REDUCE-IT Patient Subgroups by Baseline High/Low Lp(a), LDL-C Levels ---- Lp(a) Results Published...
GLG Life Tech Corporation Announces New Meeting Date for Special Shareholder Meeting
VANCOUVER, BC / ACCESSWIRE / April 6, 2024 / GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"), a global...
Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Cataract and Refractive Surgery 2024 Annual Meeting
Phase 2 data highlight consistent and sustained reductions in Intraocular Pressure (IOP), statistically significant (p<0.0001) through six months, with clinically...
2024年3月のハット8 (Hut 8) 運営アップデート
ハット8はドラムヘラー施設を閉鎖し、ソルトクリーク施設への電力供給の準備を行っているため、現在25.5 EH/sと884 MWが管理されている貸借対照表上の9,102ビットコインにより、ハット8は半減期が近づくにつれて成長への投資が可能にRead more at globenewswire.com
Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
New indication for this one-time infusion may provide patients with a treatment-free respite as early as first relapse Contacts INVESTOR...
ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
Based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s ENHERTU that showed clinically meaningful responses across a broad...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ADTH, NVEI, SWAV
NEW YORK, April 5, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ADTH, NVEI, SWAV
NEW YORK, April 5, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FUSN, LABP, DOMA
NEW YORK, April 5, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies...